Financiere de Tubize (MIL:1TUB) Other Current Payables: €0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1TUB Financiere de Tubize SA MIL:1TUB
16 GF Score
Price €247.20
! 1 Warning Sign
View Full Analysis

What is Financiere de Tubize Other Current Payables?

Financiere de Tubize MIL:1TUB 16 Other Current Payables is €0.00 Mil as of Dec. 2025. GuruFocus rates MIL:1TUB with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Financiere de Tubize's Other Current Payables for the quarter that ended in Dec. 2025 was €0.00 Mil.

Financiere de Tubize's annual Other Current Payables declined from Dec. 2023 (€43.19 Mil) to Dec. 2024 (€0.00 Mil) but then stayed the same from Dec. 2024 (€0.00 Mil) to Dec. 2025 (€0.00 Mil).

Financiere de Tubize Other Current Payables Related Terms

Financiere de Tubize Other Current Payables Historical Data

* Premium members only.

The historical data trend for Financiere de Tubize's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Financiere de Tubize Other Current Payables Chart

Financiere de Tubize Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 -0.00 43.19 0.00 0.00

Financiere de Tubize Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.19 0.00 0.00 0.00 0.00
MIL:1TUB
16GF Score
Financiere de Tubize SA MIL:1TUB
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Financiere de Tubize Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of €0.00 Mil mean?
Financiere de Tubize (MIL:1TUB) has a Other Current Payables of €0.00 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Financiere de Tubize and its competitors.
Is Financiere de Tubize's Other Current Payables too high?
Financiere de Tubize's current Other Current Payables is €0.00 Mil. Overall, Financiere de Tubize has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Financiere de Tubize's Other Current Payables compare to VRTX and REGN?
Financiere de Tubize's Other Current Payables of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Financiere de Tubize and its competitors. Financiere de Tubize's current Other Current Payables is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Financiere de Tubize stock overvalued right now?
Financiere de Tubize (MIL:1TUB) has a current Other Current Payables of €0.00 Mil. The current Other Current Payables is €0.00 Mil. Financiere de Tubize's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Financiere de Tubize (MIL:1TUB), the current Other Current Payables is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Financiere de Tubize Business Description

Address Allee de la Recherche, 60, Brussels, BEL, 1070
Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.
16GF Score

Get the complete analysis for MIL:1TUB

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€247.20
Price